ELANTAS BECK INDIA LTD.-$

Elantas Beck India Ltd announced its unaudited financial results for the quarter and half-year ended June 30, 2026. The Board of Directors approved and took on record these results, along with segment-wise financial data. The company has also provided an update regarding its Ankleshwar operations, where a closure order has been temporarily revoked until October 3, 2026, with the company expecting a positive outcome for permanent revocation. The financial results were reviewed by the Audit Committee and approved by the Board.

Standalone revenue for the quarter ended June 30, 2026 came in at ₹283.39 Cr, up 35.0% YoY from ₹209.93 Cr and 27.6% QoQ from ₹222.17 Cr in Q4 FY26. Net profit surged 80.4% YoY to ₹70.86 Cr (₹39.29 Cr a year ago) and 128.0% QoQ, with EPS at ₹89.39 versus ₹49.56 a year earlier. Profit growing well ahead of revenue signals margin expansion rather than pure volume-led growth. No consensus estimates or brokerage previews for this stock turned up in a web search, consistent with it being a small, thinly covered specialty-chemicals name — vsStreet is unknown, not a miss. The margin gain traces to input costs: cost of materials consumed fell to 58.5% of revenue from 63.1% a year ago (₹165.81 Cr on ₹283.39 Cr revenue versus ₹132.46 Cr on ₹209.93 Cr), while employee costs (+7.0% YoY) and other expenses (+5.6% YoY) grew far slower than the 35% topline gain, producing clear operating leverage. EBITDA margin (PBT plus depreciation and finance costs, excluding other income) expanded to roughly 28.8% from 18.9% YoY and 19.5% QoQ; net margin on total income rose to 23.4% from 17.2% YoY. Both segments contributed: Electrical Insulations revenue grew 30.2% YoY with segment profit up 110.6%, while Engineering & Electronic Resins and Materials grew revenue 56.5% YoY with profit up 79.7% — Insulations delivered the larger absolute profit gain. The company has no formal guidance on record and no prior concall commentary in our archive, so there is no outlook to grade this print against; the filing's accompanying letter carries only the standard board-meeting outcome, with no separate management commentary to quote. Capex intensity has stepped up alongside the print — the company committed ₹56 Cr toward a Gujarat plant capacity expansion (announced June 2, 2026), and half-year PP&E/intangible purchases already rose to ₹49.05 Cr from ₹17.40 Cr a year earlier, with capital work-in-progress up to ₹14.06 Cr from ₹8.22 Cr at December-end. Separately, the company appointed M S K A & Associates as statutory auditors in May 2026, who issued the review report on this filing. The long-running Ankleshwar (Gujarat) plant closure matter flagged by the state pollution board remains open, with the temporary revocation valid only until October 3, 2026, pending a permanent resolution.

Elantas Beck India Ltd has announced that its Board of Directors will convene on August 4, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended June 30, 2026. In line with SEBI regulations, the trading window for designated persons and their relatives will remain closed from July 1, 2026, and will reopen 48 hours after the financial results are declared. The company has also uploaded this information on its website.

Elantas Beck India Ltd has announced the closure of its trading window for dealing in the company's securities. The window will be shut from July 1, 2026, and will reopen 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending June 30, 2026. The exact date of the board meeting to approve these results will be communicated later. Designated persons and insiders are advised against trading in the company's shares during this period.

Elantas Beck India Ltd announced a significant expansion of its manufacturing capacity at its Ankleshwar plant in Gujarat. The Board of Directors has approved an investment of approximately ₹56 crores towards this expansion, which is expected to add 11,000 MT/year to the existing capacity. This move aims to support future business growth, enhance manufacturing flexibility, reduce operational bottlenecks, and improve supply reliability for key product segments. The expansion is planned to be completed within 12 months and will be financed through internal accruals. The company's existing capacity utilization stands at 90%.

Elantas Beck India Ltd's Board of Directors has approved an investment of approximately ₹56 crores for the expansion of manufacturing capacity at its Ankleshwar plant in Gujarat. The expansion aims to add 11,000 MT/year to the existing capacity, which is currently operating at 90% utilization. This strategic move is driven by future business growth, enhancing manufacturing flexibility, reducing operational bottlenecks, and strengthening supply reliability. The expansion is expected to be completed within 12 months and will be financed through internal accruals. Regulatory approvals are pending.

Elantas Beck India Ltd's Board of Directors has approved an investment of approximately ₹56 crores for the expansion of manufacturing capacity at its Ankleshwar plant in Gujarat. The expansion aims to add 11,000 MT/year to the existing capacity, which is currently operating at 90% utilization. This strategic move is driven by future business growth, enhancing manufacturing flexibility, reducing operational bottlenecks, and strengthening supply reliability. The expansion is expected to be completed within 12 months and will be financed through internal accruals. The Board meeting where this decision was made commenced on June 2, 2026.

Elantas Beck India Ltd. announced the appointment of M/s M S K A & Associates LLP as the Statutory Auditors of the company for a term of 5 years, concluding at the 75th AGM in 2031. This decision was approved by the members at the 70th Annual General Meeting held on May 12, 2026. Additionally, Mr. Nandkumar Dhekne was re-appointed as an Independent Director for a second term of five years, commencing from July 27, 2026.

Elantas Beck India Ltd. has announced the re-appointment of Mr. Nandkumar Dhekne as an Independent Director for a second term of five consecutive years, commencing from July 27, 2026, to July 26, 2031. This decision was approved by the members at the 70th Annual General Meeting held on May 12, 2026. Additionally, M S K A & Associates LLP were appointed as Statutory Auditors for five years.

Elantas Beck India Ltd. announced its unaudited financial results for the quarter ended March 31, 2026. Key highlights include total income of ₹22,512.21 Lakhs and net profit of ₹3,108.43 Lakhs. The Board of Directors approved these results in their meeting held on May 12, 2026, which commenced at 09.45 a.m. (IST) and concluded at 07.00 p.m. (IST). The statutory auditors have carried out the limited review for the quarter ended March 31, 2026.